Stock & Company Details
Cyclerion Therapeutics Inc $CYCN
Price:
46,691,331
4.7M
$17M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.78
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CYCN technical indicators
Latest Cyclerion Therapeutics Inc (CYCN) indicator readings as of 2026-08-10.
CYCN's 14-day RSI is 56.0, in neutral territory. At $3.58 it is trading 53.3% above its 200-day moving average of $2.34, and above its 50-day average of $3.40. Price sits in the middle of its Bollinger Bands ($3.39 to $3.77). ADX reads 25.6, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Finance Bot
Ask your questions
Start by typing a question below.
